Breaking the mold: nontraditional approaches to allergen immunotherapy for environmental allergens.
- 2024-10-09
- Review
- Immunotherapy 16(18-19)
- Rashi Ramchandani
- Rachel Lucyshyn
- Sophia Linton
- Anne K Ellis
- PubMed: 39382452
- DOI: 10.1080/1750743x.2024.2408216
- Low evidence
The co-administration of probiotics or monoclonal antibodies, like omalizumab, with AIT appears to improve treatment efficacy and safety.
- Effect
- Beneficial
- Effect size
- Small